Style | Citing Format |
---|---|
MLA | Maboudi A, et al.. "Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study." Dental and Medical Problems, vol. 61, no. 6, 2024, pp. 837-842. |
APA | Maboudi A, Eidi M, Lotfizadeh A, Heidari M, Rafiei A, Nabati M, Moosazadeh M, Valadan R, Kardan M, Jabbareh L (2024). Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study. Dental and Medical Problems, 61(6), 837-842. |
Chicago | Maboudi A, Eidi M, Lotfizadeh A, Heidari M, Rafiei A, Nabati M, Moosazadeh M, Valadan R, Kardan M, Jabbareh L. "Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study." Dental and Medical Problems 61, no. 6 (2024): 837-842. |
Harvard | Maboudi A et al. (2024) 'Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study', Dental and Medical Problems, 61(6), pp. 837-842. |
Vancouver | Maboudi A, Eidi M, Lotfizadeh A, Heidari M, Rafiei A, Nabati M, et al.. Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study. Dental and Medical Problems. 2024;61(6):837-842. |
BibTex | @article{ author = {Maboudi A and Eidi M and Lotfizadeh A and Heidari M and Rafiei A and Nabati M and Moosazadeh M and Valadan R and Kardan M and Jabbareh L}, title = {Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study}, journal = {Dental and Medical Problems}, volume = {61}, number = {6}, pages = {837-842}, year = {2024} } |
RIS | TY - JOUR AU - Maboudi A AU - Eidi M AU - Lotfizadeh A AU - Heidari M AU - Rafiei A AU - Nabati M AU - Moosazadeh M AU - Valadan R AU - Kardan M AU - Jabbareh L TI - Association Between Porphyromonas Gingivalis in Subgingival Plaque and Coronary Artery Disease: A Case–Control Study JO - Dental and Medical Problems VL - 61 IS - 6 SP - 837 EP - 842 PY - 2024 ER - |